Exagen (XGN)
(Delayed Data from NSDQ)
$2.40 USD
+0.36 (17.65%)
Updated Aug 5, 2024 04:00 PM ET
After-Market: $2.41 +0.01 (0.42%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth C Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/11/2024
Time: BMO |
9/2024 | $-0.37 | 0.00% |
Earnings Summary
For their last quarter, Exagen (XGN) reported earnings of -$0.16 per share, beating the Zacks Consensus Estimate of $-0.36 per share. This reflects a positive earnings surprise of 55.56%. Look out for XGN's next earnings release expected on November 11, 2024. For the next earning release, we expect the company to report earnings of -$0.37 per share, reflecting a year-over-year decrease of 28.57%.
Earnings History
Price & Consensus
Zacks News for XGN
Why Fast-paced Mover Exagen (XGN) Is a Great Choice for Value Investors
XGN: What are Zacks experts saying now?
Zacks Private Portfolio Services